CETP does not affect triglyceride production or clearance in APOE*3-Leiden mice

被引:7
|
作者
Bijland, Silvia [1 ]
van den Berg, Sjoerd A. A. [1 ]
Voshol, Peter J. [2 ]
van den Hoek, Anita M. [5 ]
Princen, Hans M. G. [5 ]
Havekes, Louis M. [2 ,3 ,4 ,5 ]
Rensen, Patrick C. N. [2 ,3 ]
van Dijk, Ko Willems [1 ,3 ]
机构
[1] Leiden Univ, Dept Human Genet, Med Ctr, NL-2300 RA Leiden, Netherlands
[2] Leiden Univ, Dept Endocrinol & Metab Dis, Med Ctr, NL-2300 RA Leiden, Netherlands
[3] Leiden Univ, Dept Gen Internal Med, Med Ctr, NL-2300 RA Leiden, Netherlands
[4] Leiden Univ, Dept Cardiol, Med Ctr, NL-2300 RA Leiden, Netherlands
[5] TNO, IVVO, Gaubius Lab, Netherlands Org Appl Sci Res Biosci, NL-2300 AK Leiden, Netherlands
关键词
cholesteryl ester transfer protein; triglyceride metabolism; HDL; postprandial lipoproteins; ESTER TRANSFER PROTEIN; HIGH-DENSITY-LIPOPROTEIN; APOLIPOPROTEIN-A-I; TRANSGENIC MICE; TORCETRAPIB; INHIBITION; EXPRESSION; VLDL; VIVO; HYPERTRIGLYCERIDEMIA;
D O I
10.1194/jlr.M900186-JLR200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The cholesteryl ester transfer protein (CETP) facilitates the bidirectional transfer of cholesteryl esters and triglycerides (TG) between HDL and (V) LDL. By shifting cholesterol in plasma from HDL to (V) LDL in exchange for VLDL-TG, CETP aggravates atherosclerosis in hyperlipidemic APOE*3-Leiden (E3L) mice. The aim of this study was to investigate the role of CETP in TG metabolism and high-fat diet-induced obesity by using E3L mice with and without the expression of the human CETP gene. On chow, plasma lipid levels were comparable between both male and female E3L and E3L. CETP mice. Further mechanistic studies were performed using male mice. CETP expression increased the level of TG in HDL. CETP did not affect the postprandial plasma TG response or the hepatic VLDL-TG and VLDL-apolipoprotein B production rate. Moreover, CETP did not affect the plasma TG clearance rate or organ-specific TG uptake after infusion of VLDL-like emulsion particles. In line with the absence of an effect of CETP on tissue-specific TG uptake, CETP also did not affect weight gain in response to a high-fat diet. In conclusion, the CETP-induced increase of TG in the HDL fraction of E3L mice is not associated with changes in the production of TG or with tissuespecific clearance of TG from the plasma.-Bijland, S., S. A. A. van den Berg, P. J. Voshol, A. M. van den Hoek, H. M. G. Princen, L. M. Havekes, P. C. N. Rensen, and K. Willems van Dijk. CETP does not affect triglyceride production or clearance in APOE*3-Leiden mice. J. Lipid Res. 2010. 51: 97-102
引用
收藏
页码:97 / 102
页数:6
相关论文
共 50 条
  • [1] Ritonavir causes hypertriglyceridaemia in APOE*3-Leiden transgenic mice by impairing triglyceride clearance
    den Boer, M
    Berbée, JFP
    Rensen, PCN
    Romijn, JA
    Reiss, P
    van der Valk, M
    Voshol, PJ
    Havekes, LM
    ANTIVIRAL THERAPY, 2004, 9 (06) : L13 - L13
  • [2] Continuous Light Does Not Affect Atherosclerosis in APOE*3-Leiden.CETP Mice
    Schilperoort, Maaike
    van den Berg, Rosa
    Coomans, Claudia P.
    Khedoe, Padmini P. S. J.
    Ramkisoensing, Ashna
    Boekestijn, Sanne
    Wang, Yanan
    Berbee, Jimmy F. P.
    Meijer, Johanna H.
    Biermasz, Nienke R.
    Rensen, Patrick C. N.
    Kooijman, Sander
    JOURNAL OF BIOLOGICAL RHYTHMS, 2020, 35 (06) : 598 - 611
  • [3] Oppositely biased glucagon-like peptide-1 receptor agonism does not differentially affect lipid metabolism in APOE*3-Leiden CETP mice
    Modder, Melanie
    Tomas, Alejandra
    Afkir, Salwa
    Pronk, Amanda C. M.
    Streefland, Trea C. M.
    Lalai, Reshma A.
    van Eenige, Robin
    Rensen, Patrick C. N.
    Jones, Ben
    Kooijman, Sander
    DIABETES OBESITY & METABOLISM, 2025,
  • [4] Hepatocyte-specific IKK-β activation enhances VLDL-triglyceride production in APOE☆3-Leiden mice
    van Diepen, Janna A.
    Wong, Man C.
    Guigas, Bruno
    Bos, Jasper
    Stienstra, Rinke
    Hodson, Leanne
    Shoelson, Steven E.
    Berbee, Jimmy F. P.
    Rensen, Patrick C. N.
    Romijn, Johannes A.
    Havekes, Louis M.
    Voshol, Peter J.
    JOURNAL OF LIPID RESEARCH, 2011, 52 (05) : 942 - 950
  • [5] The reduction of plasmatic VLDL-triglycerides by metformin is due to a specific augmentation of their clearance by brown adipose tissue in APOE*3-Leiden mice. CETP
    Geerling, J.
    van der Zon, G.
    van den Hoek, A.
    Princen, H.
    Havekes, L.
    Rensen, P.
    Guigas, B.
    DIABETES & METABOLISM, 2012, 38 : A29 - A29
  • [6] The metabolism of VLDL remnants in ApoE*3-Leiden transgenic mice
    Havekes, LM
    vanVlijmen, BJM
    Jong, MC
    Groot, PHE
    Frants, RR
    Hofker, MH
    DRUGS AFFECTING LIPID METABOLISM: RISK FACTORS AND FUTURE DIRECTIONS, 1996, 10 : 263 - 270
  • [7] Torcetrapib inhibits cholesteryl ester transfer protein and increases HDL in CETP.APOE*3-Leiden transgenic mice
    De Haan, W.
    Van der Hoogt, C. C.
    Van den Hoogen, C. M.
    Dallinga-Thie, G. M.
    Princen, H. M. G.
    Jukema, J. W.
    Havekes, L. M.
    Rensen, P. C. N.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 551 - 551
  • [8] Fenofibrate Increases Very Low Density Lipoprotein Triglyceride Production Despite Reducing Plasma Triglyceride Levels in APOE*3-Leiden.CETP Mice
    Bijland, Silvia
    Pieterman, Elsbet J.
    Maas, Annemarie C. E.
    van der Hoorn, Jose W. A.
    van Erk, Marjan J.
    van Klinken, Jan B.
    Havekes, Louis M.
    van Dijk, Ko Willems
    Princen, Hans M. G.
    Rensen, Patrick C. N.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (33) : 25168 - 25175
  • [9] Compensatory enlargement and stenosis develop in ApoE-/- and ApoE*3-Leiden transgenic mice
    Lutgens, E
    de Muinck, ED
    Heeneman, S
    Daemen, MJAP
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2001, 21 (08) : 1359 - 1365
  • [10] Ritonavir protects against the development of atherosclerosis in APOE*3-Leiden mice
    den Boer, Marion A. M.
    Westerterp, Marit
    de Vries-van der Weij, Jitske
    Wang, Yanan
    Hu, Lihui
    Santo, Sonia M. S. Espirito
    Kooistra, Teake
    Reiss, Peter
    Romijn, Johannes A.
    Havekes, Louis M.
    Rensen, Patrick C. N.
    ATHEROSCLEROSIS, 2010, 210 (02) : 381 - 387